A new hope for obesity management: Boron inhibits adipogenesis in progenitor cells through the Wnt/β-catenin pathway A Doğan, S Demirci, H Apdik, OF Bayrak, S Gulluoglu, EC Tuysuz, ... Metabolism 69, 130-142, 2017 | 62 | 2017 |
c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... Current cancer drug targets 19 (6), 479-494, 2019 | 30 | 2019 |
The role of TNF-α in chordoma progression and inflammatory pathways S Gulluoglu, EC Tuysuz, M Sahin, CK Yaltirik, A Kuskucu, F Ozkan, ... Cellular Oncology 42, 663-677, 2019 | 28 | 2019 |
Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes S Gulluoglu, EC Tuysuz, M Sahin, A Kuskucu, CK Yaltirik, U Ture, ... Brain research 1700, 199-210, 2018 | 28 | 2018 |
Leukemia inhibitory factor promotes aggressiveness of chordoma S Gulluoglu, M Sahin, EC Tuysuz, CK Yaltirik, A Kuskucu, F Ozkan, ... Oncology Research 25 (7), 1177, 2017 | 27 | 2017 |
Development of Small Molecule MEIS Inhibitors that modulate HSC activity RD Turan, E Albayrak, M Uslu, P Siyah, LY Alyazici, BM Kalkan, GS Aslan, ... Scientific reports 10 (1), 7994, 2020 | 26 | 2020 |
Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c AB Dalan, S Gulluoglu, EC Tuysuz, A Kuskucu, CK Yaltirik, O Ozturk, ... BMC cancer 17, 1-9, 2017 | 26 | 2017 |
Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells S Demirci, A Doğan, H Apdik, EC Tuysuz, S Gulluoglu, OF Bayrak, ... Molecular and cellular biochemistry 437, 133-142, 2018 | 24 | 2018 |
The potential function of microRNA in chordomas S Gulluoglu, EC Tuysuz, A Kuskucu, U Ture, B Atalay, F Sahin, OF Bayrak Gene 585 (1), 76-83, 2016 | 17 | 2016 |
Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance EC Tuysuz, S Gulluoglu, CK Yaltirik, U Ozbey, A Kuskucu, EA Çoban, ... Experimental cell research 380 (1), 9-19, 2019 | 14 | 2019 |
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy C Gialeli, EC Tuysuz, J Staaf, S Guleed, V Paciorek, M Mörgelin, ... Journal of Experimental & Clinical Cancer Research 40, 1-21, 2021 | 13 | 2021 |
Dental stem cells F Şahin, A Doğan, S Demirci Springer, 2016 | 12* | 2016 |
Small molecule‐mediated modulation of ubiquitination and neddylation improves HSC function ex vivo E Albayrak, M Uslu, S Akgol, EC Tuysuz, F Kocabas Journal of Cellular Physiology 236 (12), 8122-8136, 2021 | 11 | 2021 |
Roles of adiponectin and leptin signaling-related microRNAs in the preventive effects of calorie restriction in mammary tumor development S Dogan, MB Cicekdal, U Ozorhan, G Karabiyik, BT Kazan, ID Ekici, ... Applied Physiology, Nutrition, and Metabolism 46 (8), 866-876, 2021 | 11 | 2021 |
miRNAs as cell fate determinants of lateral and paraxial mesoderm differentiation from embryonic stem cells EC Tuysuz, U Ozbey, S Gulluoglu, A Kuskucu, F Sahin, OF Bayrak Developmental Biology 478, 212-221, 2021 | 5 | 2021 |
Co-polysomy of 1p/19q in glial tumors: Retrospective analysis of 221 cases from single center A Kuskucu, EC Tuysuz, S Gurkan, Z Demir, CK Yaltirik, F Ozkan, ID Ekici, ... Gene 701, 161-168, 2019 | 1 | 2019 |
c-Myc inhibition is critical for HSC expansion and Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... bioRxiv, 403584, 2018 | 1 | 2018 |
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas EC Tuysuz, E Mourati, R Rosberg, A Moskal, C Gialeli, E Johansson, ... Journal of Experimental & Clinical Cancer Research 43 (1), 98, 2024 | | 2024 |
COMPLEMENT FACTOR H IS A NOVEL LIGAND FOR THE INDUCIBLE T CELL CO-STIMULATOR AND PROMOTES SURVIVAL OF REGULATORY T CELLS IN THE GLIOMA MICROENVIRONMENT K Smolag, J Olszowka, R Rosberg, E Johansson, E Marinko, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
27 Elucidating the molecular mechanisms mediating the tumor suppressive actions of complement inhibitor CSMD1 in gliomas EC Tuysuz, E Mourati, C Gialeli, KI Smolag, E Johansson, R Rosberg, ... Immunobiology 228 (5), 152484, 2023 | | 2023 |